Myriad Collaborative Research Registry

Welcome

The Myriad Collaborative Research Registry advances patient care by combining structured clinical data with genetic and genome testing. The overarching goal is to create an environment for improving and advancing cancer care.

Sign up to access the registry

If you would like to access the registry, please include your contact information and someone from our team will contact you soon.

Precise Registry Form - Provider

I have read and accepted the EULA Agreement
Hidden Fields









Frequently asked questions

  • What is the purpose of the Myriad Collaborative Research Registry (MCRR)?
    To advance cancer care by providing research opportunities and fostering partnerships with clinicians.
  • What type of information will be in the MCRR?

    The registry is pre-loaded with de-identified data on >1.1 million patients. This includes genetic and genome results along with clinical components from test requisition forms (TRF). Numerous Myriad tests are included across multiple cancer types. Immediate data exploration is available for researchers who have been trained on the MCRR dashboard.

  • What types of analysis can be done with data in MCRR?

    Once access is granted to the research portal, users will be able to carry out queries and analyses that will help inform and foster research opportunities.

    Some examples include:

    • Explore treatment and medical decision making across cohorts
    • Expand somatic-germline interactions and associations
    • Evaluate outcomes (in process) from different treatments based on ancestry, demographics, lifestyle, etc.
    • Compare individual data (in process) to aggregate group datasets
  • After I have access to MCRR how do I move forward with a research idea for publication?
    After completing a End User License Agreement and receiving training on the MCRR dashboard, you can access specific data. Complete a Research Concept Form outlining your proposed research idea. This will be evaluated by Myriad and, if approved, an IRB will be requested. Final approval of research activity is required by Myriad.
  • Where do I go for help with MCRR?

    The trainer orienting you to MCRR dashboard is available for support to navigate the registry. Contact [email protected] for triage to other experts as appropriate.

Learn more about our suite of solutions

Precise Logo Black
Germline

Germline
(FDA-Approved)

BRACAnalysisCDx

Germline
(Non-FDA-Approved)

MyRisk
HRD status
Tumor profiling

HRDstatus
(FDA-Approved)

MyChoiceCDx
Tumor profiling

Tumor profilingstatus
(Non-FDA-Approved)

Precise Tumor

For patients with ovarian cancer
Precise Tumor is powered by Intermountain Precision Genomics, a service of Intermountain® Healthcare

Myriad Collaborative Research Registry™ Researcher Enroll product signature

Prolaris® is a molecular diagnostic test that measures the expression level of genes involved with tumor proliferation to predict disease outcome. Prolaris can be used in conjunction with other clinical parameters to determine prostate cancer aggressiveness.

Learn more

Prolaris® is a molecular diagnostic test that measures the expression level of genes involved with tumor proliferation to predict disease outcome. Prolaris can be used in conjunction with other clinical parameters to determine prostate cancer aggressiveness.

Learn more